Global NGS-based RNA-seq Industry

NEW YORK, Oct. 21, 2020 /PRNewswire/ -- Amid the COVID-19 crisis, the global market for NGS-based RNA-seq estimated at US$1.5 Billion in the year 2020, is projected to reach a revised size of US$5.3 Billion by 2027, growing at a CAGR of 19.9% over the analysis period 2020-2027. Sample Preparation, one of the segments analyzed in the report, is projected to record a 16% CAGR and reach US$998.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Sequencing Platforms & Consumables for RNA-Seq segment is readjusted to a revised 22.8% CAGR for the next 7-year period.



Read the full report: https://www.reportlinker.com/p05799235/?utm_source=PRN



The U.S. Market is Estimated at $438 Million, While China is Forecast to Grow at 19.3% CAGR

The NGS-based RNA-seq market in the U.S. is estimated at US$438 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$918.6 Million by the year 2027 trailing a CAGR of 19.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.8% and 17.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 14.8% CAGR.

RNA Sequencing Services Segment to Record 20.2% CAGR

In the global RNA Sequencing Services segment, USA, Canada, Japan, China and Europe will drive the 20% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$284 Million in the year 2020 will reach a projected size of US$1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$654.6 Million by the year 2027.We bring years of research experience to this 9th edition of our report. The 218-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

• Agilent Technologies, Inc.
• Eurofins Scientific
• F. Hoffmann-La Roche AG
• GATC Biotech AG
• Illumina, Inc.
• Macrogen, Inc.
• Oxford Nanopore Technologies Ltd.
• Pacific Biosciences of California, Inc.
• PerkinElmer, Inc.
• Qiagen NV
• Thermo Fisher Scientific, Inc.

Read the full report: https://www.reportlinker.com/p05799235/?utm_source=PRN

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
RNA-Seq: An Introduction
A Prelude to NGS-based RNA-seq Market
North America: The Largest Market for NGS-based RNA-seq
Global Competitor Market Shares
NGS-based RNA-seq Competitor Market Share Scenario Worldwide:
(in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
NGS-based RNA-seq Market Drivers and Restraints
Recent Advances in RNA Sequence Analysis
Select Players of NGS-based RNA-seq Market
Rise in Research Grants to Improve Activities in NGS-based RNA
-Sequencing Technique
Application of RNA-Seq in Precision Medicine
Next Generation Sequencing in Cancer Research
Next Generation Sequencing for Transcriptomic Profiling

4. GLOBAL MARKET PERSPECTIVE
Table 1: NGS-based RNA-seq Global Market Estimates and
Forecasts in US$ Thousand by Region/Country: 2020-2027

Table 2: NGS-based RNA-seq Market Share Shift across Key
Geographies Worldwide: 2020 VS 2027

Table 3: Sample Preparation (Products & Services) World Market
by Region/Country in US$ Thousand: 2020 to 2027

Table 4: Sample Preparation (Products & Services) Market Share
Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027

Table 5: Sequencing Platforms & Consumables for RNA-Seq
(Products & Services) Potential Growth Markets Worldwide in US$
Thousand: 2020 to 2027

Table 6: Sequencing Platforms & Consumables for RNA-Seq
(Products & Services) Market Sales Breakdown by Region/Country
in Percentage: 2020 VS 2027

Table 7: RNA Sequencing Services (Products & Services)
Geographic Market Spread Worldwide in US$ Thousand: 2020 to
2027

Table 8: RNA Sequencing Services (Products & Services) Market
Share Distribution in Percentage by Region/Country: 2020 VS
2027

Table 9: Data Analysis, Storage, and Management (Products &
Services) World Market Estimates and Forecasts by
Region/Country in US$ Thousand: 2020 to 2027

Table 10: Data Analysis, Storage, and Management (Products &
Services) Market Share Breakdown by Region/Country: 2020 VS
2027

Table 11: Sequencing by Synthesis (SBS) (Technology) World
Market by Region/Country in US$ Thousand: 2020 to 2027

Table 12: Sequencing by Synthesis (SBS) (Technology) Market
Share Distribution in Percentage by Region/Country: 2020 VS
2027

Table 13: Ion Semiconductor Sequencing (Technology) World
Market Estimates and Forecasts in US$ Thousand by
Region/Country: 2020 to 2027

Table 14: Ion Semiconductor Sequencing (Technology) Market
Percentage Share Distribution by Region/Country: 2020 VS 2027

Table 15: Single-molecule Real-time (SMRT) Sequencing
(Technology) Market Opportunity Analysis Worldwide in US$
Thousand by Region/Country: 2020 to 2027

Table 16: Single-molecule Real-time (SMRT) Sequencing
(Technology) Market Share Distribution in Percentage by
Region/Country: 2020 VS 2027

Table 17: Nanopore Sequencing (Technology) World Market by
Region/Country in US$ Thousand: 2020 to 2027

Table 18: Nanopore Sequencing (Technology) Market Share
Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027

Table 19: De Novo Transcriptome Assembly (Application) Global
Market Estimates & Forecasts in US$ Thousand by Region/Country:
2020-2027

Table 20: De Novo Transcriptome Assembly (Application) Market
Share Breakdown by Region/Country: 2020 VS 2027

Table 21: Expression Profiling Analysis (Application) Demand
Potential Worldwide in US$ Thousand by Region/Country:
2020-2027

Table 22: Expression Profiling Analysis (Application) Share
Breakdown Review by Region/Country: 2020 VS 2027

Table 23: Variant Calling and Transcriptome Epigenetics
(Application) Worldwide Latent Demand Forecasts in US$ Thousand
by Region/Country: 2020-2027

Table 24: Variant Calling and Transcriptome Epigenetics
(Application) Distribution of Global Sales by Region/Country:
2020 VS 2027

Table 25: Small RNA Sequencing (Application) Sales Estimates
and Forecasts in US$ Thousand by Region/Country for the Years
2020 through 2027

Table 26: Small RNA Sequencing (Application) Global Market
Share Distribution by Region/Country for 2020 and 2027

Table 27: Research Centers & Academic & Government Institutes
(End-Use) Global Opportunity Assessment in US$ Thousand by
Region/Country: 2020-2027

Table 28: Research Centers & Academic & Government Institutes
(End-Use) Percentage Share Breakdown of Global Sales by
Region/Country: 2020 VS 2027

Table 29: Hospitals & Clinics (End-Use) Worldwide Sales in US$
Thousand by Region/Country: 2020-2027

Table 30: Hospitals & Clinics (End-Use) Market Share Shift
across Key Geographies: 2020 VS 2027

Table 31: Pharmaceutical & Biotechnology Companies (End-Use)
Global Market Estimates & Forecasts in US$ Thousand by
Region/Country: 2020-2027

Table 32: Pharmaceutical & Biotechnology Companies (End-Use)
Market Share Breakdown by Region/Country: 2020 VS 2027

Table 33: Other End-Uses (End-Use) Demand Potential Worldwide
in US$ Thousand by Region/Country: 2020-2027

Table 34: Other End-Uses (End-Use) Share Breakdown Review by
Region/Country: 2020 VS 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US NGS-based RNA-seq Market Share (in %) by Company: 2019 & 2025
Market Analytics
Table 35: United States NGS-based RNA-seq Market Estimates and
Projections in US$ Thousand by Products & Services: 2020 to
2027

Table 36: United States NGS-based RNA-seq Market Share
Breakdown by Products & Services: 2020 VS 2027

Table 37: NGS-based RNA-seq Market in US$ Thousand in the
United States by Technology: 2020-2027

Table 38: United States NGS-based RNA-seq Market Share
Breakdown by Technology: 2020 VS 2027

Table 39: United States NGS-based RNA-seq Latent Demand
Forecasts in US$ Thousand by Application: 2020 to 2027

Table 40: NGS-based RNA-seq Market Share Breakdown in the
United States by Application: 2020 VS 2027

Table 41: United States NGS-based RNA-seq Latent Demand
Forecasts in US$ Thousand by End-Use: 2020 to 2027

Table 42: NGS-based RNA-seq Market Share Breakdown in the
United States by End-Use: 2020 VS 2027

CANADA
Table 43: Canadian NGS-based RNA-seq Market Estimates and
Forecasts in US$ Thousand by Products & Services: 2020 to 2027

Table 44: NGS-based RNA-seq Market in Canada: Percentage Share
Breakdown of Sales by Products & Services for 2020 and 2027

Table 45: NGS-based RNA-seq Market Analysis in Canada in US$
Thousand by Technology: 2020-2027

Table 46: Canadian NGS-based RNA-seq Market Share Breakdown by
Technology: 2020 VS 2027

Table 47: Canadian NGS-based RNA-seq Market Quantitative Demand
Analysis in US$ Thousand by Application: 2020 to 2027

Table 48: Canadian NGS-based RNA-seq Market Share Analysis by
Application: 2020 VS 2027

Table 49: Canadian NGS-based RNA-seq Market Quantitative Demand
Analysis in US$ Thousand by End-Use: 2020 to 2027

Table 50: Canadian NGS-based RNA-seq Market Share Analysis by
End-Use: 2020 VS 2027

JAPAN
Table 51: Japanese Market for NGS-based RNA-seq: Annual Sales
Estimates and Projections in US$ Thousand by Products &
Services for the Period 2020-2027

Table 52: Japanese NGS-based RNA-seq Market Share Analysis by
Products & Services: 2020 VS 2027

Table 53: Japanese Medium & Long-Term Outlook for NGS-based
RNA-seq Market in US$ Thousand by Technology: 2020-2027

Table 54: Japanese NGS-based RNA-seq Market Percentage Share
Distribution by Technology: 2020 VS 2027

Table 55: Japanese Demand Estimates and Forecasts for NGS-based
RNA-seq in US$ Thousand by Application: 2020 to 2027

Table 56: NGS-based RNA-seq Market Share Shift in Japan by
Application: 2020 VS 2027

Table 57: Japanese Demand Estimates and Forecasts for NGS-based
RNA-seq in US$ Thousand by End-Use: 2020 to 2027

Table 58: NGS-based RNA-seq Market Share Shift in Japan by
End-Use: 2020 VS 2027

CHINA
Table 59: Chinese NGS-based RNA-seq Market Growth Prospects in
US$ Thousand by Products & Services for the Period 2020-2027

Table 60: Chinese NGS-based RNA-seq Market by Products &
Services: Percentage Breakdown of Sales for 2020 and 2027

Table 61: NGS-based RNA-seq Market Estimates and Forecasts in
China in US$ Thousand by Technology: 2020-2027

Table 62: NGS-based RNA-seq Market in China: Percentage Share
Analysis by Technology for 2020 and 2027

Table 63: Chinese Demand for NGS-based RNA-seq in US$ Thousand
by Application: 2020 to 2027

Table 64: Chinese NGS-based RNA-seq Market Share Breakdown by
Application: 2020 VS 2027

Table 65: Chinese Demand for NGS-based RNA-seq in US$ Thousand
by End-Use: 2020 to 2027

Table 66: Chinese NGS-based RNA-seq Market Share Breakdown by
End-Use: 2020 VS 2027

EUROPE
Market Facts & Figures
European NGS-based RNA-seq Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Market Analytics
Table 67: European NGS-based RNA-seq Market Demand Scenario in
US$ Thousand by Region/Country: 2018-2025

Table 68: European NGS-based RNA-seq Market Share Shift by
Region/Country: 2020 VS 2027

Table 69: European NGS-based RNA-seq Market Estimates and
Forecasts in US$ Thousand by Products & Services: 2020-2027

Table 70: European NGS-based RNA-seq Market Share Breakdown by
Products & Services: 2020 VS 2027

Table 71: European NGS-based RNA-seq Market Assessment in US$
Thousand by Technology: 2020-2027

Table 72: NGS-based RNA-seq Market in Europe: Percentage
Breakdown of Sales by Technology for 2020 and 2027

Table 73: European NGS-based RNA-seq Addressable Market
Opportunity in US$ Thousand by Application: 2020-2027

Table 74: European NGS-based RNA-seq Market Share Analysis by
Application: 2020 VS 2027

Table 75: European NGS-based RNA-seq Addressable Market
Opportunity in US$ Thousand by End-Use: 2020-2027

Table 76: European NGS-based RNA-seq Market Share Analysis by
End-Use: 2020 VS 2027

FRANCE
Table 77: NGS-based RNA-seq Market in France by Products &
Services: Estimates and Projections in US$ Thousand for the
Period 2020-2027

Table 78: French NGS-based RNA-seq Market Share Analysis by
Products & Services: 2020 VS 2027

Table 79: French NGS-based RNA-seq Market Estimates and
Projections in US$ Thousand by Technology: 2020-2027

Table 80: French NGS-based RNA-seq Market Share Breakdown by
Technology: 2020 VS 2027

Table 81: NGS-based RNA-seq Quantitative Demand Analysis in
France in US$ Thousand by Application: 2020-2027

Table 82: French NGS-based RNA-seq Market Share Analysis:
A 7-Year Perspective by Application for 2020 and 2027

Table 83: NGS-based RNA-seq Quantitative Demand Analysis in
France in US$ Thousand by End-Use: 2020-2027

Table 84: French NGS-based RNA-seq Market Share Analysis:
A 7-Year Perspective by End-Use for 2020 and 2027

GERMANY
Table 85: NGS-based RNA-seq Market in Germany: Recent Past,
Current and Future Analysis in US$ Thousand by Products &
Services for the Period 2020-2027

Table 86: German NGS-based RNA-seq Market Share Breakdown by
Products & Services: 2020 VS 2027

Table 87: German NGS-based RNA-seq Latent Demand Forecasts in
US$ Thousand by Technology: 2020-2027

Table 88: German NGS-based RNA-seq Market Share Breakdown by
Technology: 2020 VS 2027

Table 89: NGS-based RNA-seq Market in Germany: Annual Sales
Estimates and Forecasts in US$ Thousand by Application for the
Period 2020-2027

Table 90: NGS-based RNA-seq Market Share Distribution in
Germany by Application: 2020 VS 2027

Table 91: NGS-based RNA-seq Market in Germany: Annual Sales
Estimates and Forecasts in US$ Thousand by End-Use for the
Period 2020-2027

Table 92: NGS-based RNA-seq Market Share Distribution in
Germany by End-Use: 2020 VS 2027

ITALY
Table 93: Italian NGS-based RNA-seq Market Growth Prospects in
US$ Thousand by Products & Services for the Period 2020-2027

Table 94: Italian NGS-based RNA-seq Market by Products &
Services: Percentage Breakdown of Sales for 2020 and 2027

Table 95: NGS-based RNA-seq Market Estimates and Forecasts in
Italy in US$ Thousand by Technology: 2020-2027

Table 96: NGS-based RNA-seq Market in Italy: Percentage Share
Analysis by Technology for 2020 and 2027

Table 97: Italian Demand for NGS-based RNA-seq in US$ Thousand
by Application: 2020 to 2027

Table 98: Italian NGS-based RNA-seq Market Share Breakdown by
Application: 2020 VS 2027

Table 99: Italian Demand for NGS-based RNA-seq in US$ Thousand
by End-Use: 2020 to 2027

Table 100: Italian NGS-based RNA-seq Market Share Breakdown by
End-Use: 2020 VS 2027

UNITED KINGDOM
Table 101: United Kingdom Market for NGS-based RNA-seq: Annual
Sales Estimates and Projections in US$ Thousand by Products &
Services for the Period 2020-2027

Table 102: United Kingdom NGS-based RNA-seq Market Share
Analysis by Products & Services: 2020 VS 2027

Table 103: United Kingdom Medium & Long-Term Outlook for
NGS-based RNA-seq Market in US$ Thousand by Technology:
2020-2027

Table 104: United Kingdom NGS-based RNA-seq Market Percentage
Share Distribution by Technology: 2020 VS 2027

Table 105: United Kingdom Demand Estimates and Forecasts for
NGS-based RNA-seq in US$ Thousand by Application: 2020 to 2027

Table 106: NGS-based RNA-seq Market Share Shift in the United
Kingdom by Application: 2020 VS 2027

Table 107: United Kingdom Demand Estimates and Forecasts for
NGS-based RNA-seq in US$ Thousand by End-Use: 2020 to 2027

Table 108: NGS-based RNA-seq Market Share Shift in the United
Kingdom by End-Use: 2020 VS 2027

REST OF EUROPE
Table 109: Rest of Europe NGS-based RNA-seq Market Estimates
and Forecasts in US$ Thousand by Products & Services: 2020-2027

Table 110: Rest of Europe NGS-based RNA-seq Market Share
Breakdown by Products & Services: 2020 VS 2027

Table 111: Rest of Europe NGS-based RNA-seq Market Assessment
in US$ Thousand by Technology: 2020-2027

Table 112: NGS-based RNA-seq Market in Rest of Europe:
Percentage Breakdown of Sales by Technology for 2020 and 2027

Table 113: Rest of Europe NGS-based RNA-seq Addressable Market
Opportunity in US$ Thousand by Application: 2020-2027

Table 114: Rest of Europe NGS-based RNA-seq Market Share
Analysis by Application: 2020 VS 2027

Table 115: Rest of Europe NGS-based RNA-seq Addressable Market
Opportunity in US$ Thousand by End-Use: 2020-2027

Table 116: Rest of Europe NGS-based RNA-seq Market Share
Analysis by End-Use: 2020 VS 2027

ASIA-PACIFIC
Table 117: NGS-based RNA-seq Market in Asia-Pacific by Products &
Services: Estimates and Projections in US$ Thousand for the
Period 2020-2027

Table 118: Asia-Pacific NGS-based RNA-seq Market Share Analysis
by Products & Services: 2020 VS 2027

Table 119: Asia-Pacific NGS-based RNA-seq Market Estimates and
Projections in US$ Thousand by Technology: 2020-2027

Table 120: Asia-Pacific NGS-based RNA-seq Historic Market
Analysis in US$ Thousand by Technology: 2020 VS 2027

Table 121: NGS-based RNA-seq Quantitative Demand Analysis in
Asia-Pacific in US$ Thousand by Application: 2020-2027

Table 122: Asia-Pacific NGS-based RNA-seq Market Share
Analysis: A 7-Year Perspective by Application for 2020 and 2027

Table 123: NGS-based RNA-seq Quantitative Demand Analysis in
Asia-Pacific in US$ Thousand by End-Use: 2020-2027

Table 124: Asia-Pacific NGS-based RNA-seq Market Share
Analysis: A 7-Year Perspective by End-Use for 2020 and 2027

REST OF WORLD
Table 125: Rest of World NGS-based RNA-seq Market Estimates and
Forecasts in US$ Thousand by Products & Services: 2020 to 2027

Table 126: NGS-based RNA-seq Market in Rest of World:
Percentage Share Breakdown of Sales by Products & Services for
2020 and 2027

Table 127: NGS-based RNA-seq Market Analysis in Rest of World
in US$ Thousand by Technology: 2020-2027

Table 128: Rest of World NGS-based RNA-seq Market Share
Breakdown by Technology: 2020 VS 2027

Table 129: Rest of World NGS-based RNA-seq Market Quantitative
Demand Analysis in US$ Thousand by Application: 2020 to 2027

Table 130: Rest of World NGS-based RNA-seq Market Share
Analysis by Application: 2020 VS 2027

Table 131: Rest of World NGS-based RNA-seq Market Quantitative
Demand Analysis in US$ Thousand by End-Use: 2020 to 2027

Table 132: Rest of World NGS-based RNA-seq Market Share
Analysis by End-Use: 2020 VS 2027

IV. COMPETITION
Total Companies Profiled: 46
Read the full report: https://www.reportlinker.com/p05799235/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]  
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

Related Links

www.reportlinker.com